DALE STEPHEN 4
4 · Kura Oncology, Inc. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
DALE STEPHEN
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-01-27$13.89/sh−4,385$60,909→ 32,515 total - Sale
Common Stock
2023-01-27$13.87/sh−4,840$67,124→ 27,675 total
Footnotes (3)
- [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
- [F2]This transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2022.
- [F3]This transaction was executed in multiple trades at prices ranging from $13.62 to $14.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.